98
Views
0
CrossRef citations to date
0
Altmetric
Perspective

Inflammation, Atherosclerosis and Hypertension: The Impact of Depression and Stress on their Complex Relationship

, ORCID Icon & ORCID Icon
Pages 27-33 | Received 21 Feb 2023, Accepted 28 Nov 2023, Published online: 21 Dec 2023

References

  • Bkaily G , Jacques D . Morphological and functional remodeling of vascular endothelium in cardiovascular diseases. Int. J. Mol. Sci. J. 24(3), 1998 (2023).
  • Sachse M , Tual-Chalot S , Ciliberti G et al. RNA-binding proteins in vascular inflammation and atherosclerosis. Atherosclerosis S0021-9150(23), 00009-6 (2023).
  • Bauer R , Brüne B , Schmid T . Cholesterol metabolism in the regulation of inflammatory responses. Front. Pharmacol. 14, 1121819 (2023).
  • Henein MY , Vancheri S , Longo G , Vancheri F . The role of inflammation in cardiovascular disease. Int. J. Mol. Sci. 23(21), 12906 (2022).
  • D’Ascenzi F , Sciaccaluga C , Cameli M et al. When should cardiovascular prevention begin? The importance of antenatal, perinatal and primordial prevention. Eur. J. Prev. Cardiol. 2047487319893832 (2019).
  • Taghizadeh E , Taheri F , Renani PG , Reiner Ž , Navashenaq JG , Sahebkar A . Macrophage: a key therapeutic target in atherosclerosis? Curr. Pharm. Des. 25(29), 3165–3174 (2019).
  • Ciccarelli G , Conte S , Cimmino G , Maiorano P , Morrione A , Giordano A . Mitochondrial dysfunction: the hidden player in the pathogenesis of atherosclerosis? Int. J. Mol. Sci. 24(2), 1086 (2023).
  • Guo X , Ma L . Inflammation in coronary artery disease-clinical implications of novel HDL-cholesterol-related inflammatory parameters as predictors. Coron. Artery Dis. 34(1), 66–77 (2023).
  • Frąk W , Wojtasińska A , Lisińska W , Młynarska E , Franczyk B , Rysz J . Pathophysiology of cardiovascular diseases: new insights into molecular mechanisms of atherosclerosis, arterial hypertension, and coronary artery disease. Biomedicines 10(8), 1938 (2022).
  • Ajala ON , Demler OV , Liu Y et al. Anti-inflammatory HDL function, incident cardiovascular events, and mortality: a secondary analysis of the JUPITER randomized clinical trial. J. Am. Heart Assoc. 9(17), e016507 (2020).
  • Ridker PM , Danielson E , Fonseca FA et al. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet 373, 1175–1182 (2009).
  • Nurmohamed N , Naver A , Kastelein J . New and emerging therapies for reduction of LDL cholesterol and apolipoprotein B: JACC focus seminar. J. Am. Coll. Cardiol. 77, 1564–1575 (2021).
  • Ridker P , Bhatt D , Pradhan A et al. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomized trials. Lancet 401, 1293–1301 (2023).
  • Nelson K , Fuster V , Ridker PM . Low-dose colchicine for secondary prevention of coronary artery disease: JACC review topic of the week. J. Am. Coll. Cardiol. 82(7), 648–660 (2023).
  • Kumar D , Pandit R , Yurdagul A Jr . Mechanisms of continual efferocytosis by macrophages and its role in mitigating atherosclerosis. Immunometabolism 5(1), e00017 (2023).
  • Zanini G , Selleri V , Lopez Domenech S et al. Mitochondrial DNA as inflammatory DAMP: a warning of an aging immune system? Biochem. Soc. Trans. 51(2), 735–745 (2023).
  • Kiełbowski K , Bakinowska E , Pawlik A . The potential role of connexins in the pathogenesis of atherosclerosis. Int. J. Mol. Sci. 24(3), 2600 (2023).
  • An J , Zhang Y , Zhou H et al. Incidence of atherosclerotic cardiovascular disease in young adults at low short-term but high long-term risk. J. Am. Coll. Cardiol. 81(7), 623–632 (2023).
  • Cimmino G , Muscoli S , De Rosa S et al. Evolving concepts in the pathophysiology of atherosclerosis: from endothelial dysfunction to thrombus formation through multiple shades of inflammation. J. Cardiovasc. Med. (Hagerstown) 24(Suppl. 2), e156–e167 (2023).
  • Ferdinandy P , Andreadou I , Baxter GF et al. Interaction of cardiovascular nonmodifiable risk factors, comorbidities and comedications with ischemia/reperfusion injury and cardioprotection by pharmacological treatments and ischemic conditioning. Pharmacol. Rev. 75(1), 159–216 (2023).
  • Mattioli AV , Moscucci F , Sciomer S et al. Cardiovascular prevention in women: un update By the Italian Society of Cardiology Working Group On “Prevention, hypertension and peripheral disease”. J. Cardiovasc. Med. (Hagerstown) 24(Suppl. 2), e147–e155 (2023).
  • Luo C , Ruan Y , Sun P et al. The role of transcription factors in coronary artery disease and myocardial infarction. Front. Biosci. (Landmark Ed). 27(12), 329 (2022).
  • Shuvalova YA , Kaminnaya V , Kaminnyi AI . Contribution of Interleukin-6 system genes polymorphisms to the development of coronary atherosclerosis. Gene 861, 147253 (2023).
  • Batty M , Bennett MR , Yu E . The role of oxidative stress in atherosclerosis. Cells 11(23), 3843 (2022).
  • Zhang Z , Zhao L , Zhou X , Meng X , Zhou X . Role of inflammation, immunity, and oxidative stress in hypertension: new insights and potential therapeutic targets. Front. Immunol. 13, 1098725 (2023).
  • Mattioli AV , Coppi F , Bucciarelli V , Gallina S . Cardiovascular risk stratification in young women: the pivotal role of pregnancy. J. Cardiovasc. Med. (Hagerstown) 24(11), 793–797 (2023).
  • Cadeddu C , Franconi F , Cassisa L et al. Arterial hypertension in the female world: pathophysiology and therapy. J. Cardiovasc. Med. (Hagerstown) 17(4), 229–236 (2016).
  • Cameli M , Lembo M , Sciaccaluga C et al. Identification of cardiac organ damage in arterial hypertension: insights by echocardiography for a comprehensive assessment. J. Hypertens. 38(4), 588–598 (2020).
  • Harsanyi S , Kupcova I , Danisovic L , Klein M . Selected biomarkers of depression: what are the effects of cytokines and inflammation? Int. J. Mol. Sci. 24(1), 578 (2022).
  • Mattioli AV , Coppi F , Nasi M , Gallina S . Stress and cardiovascular risk burden after the pandemic: current status and future prospects. Expert. Rev. Cardiovasc. Ther. 20(7), 507–513 (2022).
  • Liu ST , Lin SC , Chang JP et al. The clinical observation of inflammation theory for depression: the initiative of the Formosa Long COVID Multicenter Study (FOCuS). Clin. Psychopharmacol. Neurosci. 21(1), 10–18 (2023).
  • Simon MS , Arteaga-Henríquez G , Fouad Algendy A , Siepmann T , Illigens BMW . Anti-Inflammatory treatment efficacy in major depressive disorder: a systematic review of meta-analyses. Neuropsychiatr. Dis. Treat. 19, 1–25 (2023).
  • Silverman AL , Herzog AA , Silverman DI . Hearts and minds: stress, anxiety, and depression: unsung risk factors for cardiovascular disease. Cardiol. Rev. 27(4), 202–207 (2019).
  • Lu S , Wei F , Li G . The evolution of the concept of stress and the framework of the stress system. Cell Stress 5(6), 76–85 (2021).
  • Popovic D , Popovic B , Plecas-Solarovic B et al. The interface of hypothalamic-pituitaryadrenocortical axis and circulating brain natriuretic peptide in prediction of cardiopulmonary performance during physical stress. Peptides 47, 85–93 (2013).
  • Goldstein BI , Carnethon MR , Matthews KA et al. Major depressive disorder and bipolar disorder predispose youth to accelerated atherosclerosis and early cardiovascular disease: a scientific statement from the American Heart Association. Circulation 132, 965–986 (2015).
  • Lichtman JH , Froelicher ES , Blumenthal JA et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation 129, 1350–1369 (2014).
  • Cocchi C , Coppi F , Farinetti A , Mattioli AV . Cardiovascular disease prevention and therapy in women with Type 2 diabetes. Future Cardiol. 17(3), 487–496 (2021).
  • Stein M . Stress, depression, and the immune system. J. Clin. Psychiatry 50(Suppl. 35–40), 41–42 (1989).
  • Kivimaki M , Steptoe A . Effects of stress on the development and progression of cardiovascular disease. Nat. Rev. Cardiol. 15, 215–229 (2018).
  • García-Lara RA , Suleiman-Martos N , Membrive-Jiménez MJ et al. Prevalence of depression and related factors among patients with chronic disease during the COVID-19 pandemic: a systematic review and meta-analysis. Diagnostics (Basel) 12(12), 3094 (2022).
  • Tsai FJ , Shen SW . Concepts of dementia prevention in the health promotion among older adults: a narrative review. Medicine (Baltimore) 101(50), e3212 (2022).
  • Mattioli AV , Selleri V , Zanini G et al. Physical activity and diet in older women: a narrative review. J. Clin. Med. 12, 81 (2023).
  • Rickles NM , Sharma M , Harrow S , Silverwatch J . A narrative review: pharmacy intervention fidelity. J. Am. Pharm. Assoc. S1544-3191(22)00355-7 (2022).
  • Vogel B , Acevedo M , Appelman Y et al. The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. Lancet 397(10292), 2385–2438 (2021).
  • Mattioli AV , Nasi M , Cocchi C , Farinetti A . COVID 19 outbreak: impact of the quarantine-induced stress on cardiovascular disease risk burden. Future Cardiol. 16(6), 539–542 (2020).
  • Almeida M , Shrestha AD , Stojanac D , Miller LJ . The impact of the COVID-19 pandemic on women’s mental health. Arch. Womens Ment. Health 23(6), 741–748 (2020).
  • Azizi Z , Alipour P , Raparelli V , Norris CM , Pilote L . The role of sex and gender in hypertension. J. Hum. Hypertens. 37(8), 589–595 (2023).
  • Coppi F , Nasi M , Farinetti A et al. Physical activity, sedentary behaviour, and diet in menopausal women: comparison between COVID19 “first wave” and “second wave” of pandemic in Italy. Progress Nutrition 23(2), 11755 (2021).
  • Kabra A , Garg R , Brimson J et al. Mechanistic insights into the role of plant polyphenols and their nano-formulations in the management of depression. Front. Pharmacol. 13, 1046599 (2022).
  • Truzzi ML , Ballerini Puviani M , Tripodi A et al. Mediterranean diet as a model of sustainable, resilient and healthy diet. Progr. Nutr. 22, 388–394 (2020).
  • Mahajan A , Bandaru D , Parikh K , Gupta V , Patel M . From the inside out: understanding the gut–heart connection. Future Cardiol. 19(10), 505–514 (2023).
  • Mattioli AV , Migaldi M , Farinetti A . Coffee in hypertensive women with asymptomatic peripheral arterial disease: a potential nutraceutical effect. J. Cardiovasc. Med. (Hagerstown) 19(4), 183–185 (2018).
  • Jumar A , Schmieder RE . Cocoa flavanol cardiovascular effects beyond blood pressure reduction. J. Clin. Hypertens. (Greenwich) 18, 352–358 (2016).
  • Begdache L , Sadeghzadeh S , Derose G , Abrams C . Diet, exercise, lifestyle, and mental distress among young and mature men and women: a repeated cross-sectional study. Nutrients 13(1), 24 (2020).
  • Torres SJ , Nowson CA . Relationship between stress, eating behavior, and obesity. Nutrition 23(11–12), 887–894 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.